What is the ticker symbol for 20/20 Biolabs?

20/20 Biolabs trades under the ticker AIDX on NASDAQ.

What sector does 20/20 Biolabs operate in?

20/20 Biolabs is classified in the Healthcare sector (Medical - Care Facilities industry).

How can PortView help analyze AIDX in a portfolio?

PortView shows AIDX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

20/20 Biolabs (AIDX) Stock Analysis

NASDAQHealthcareMedical - Care Facilities

$0.62+1.06%

1-year price historyRange $0.40 – $23.85

52-week range$0.62

$0.40$50.00

What 20/20 Biolabs does

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.

Key metrics

Market cap

$7.62M

P/E (TTM)

-1.17

EPS (TTM)

$-0.53

Beta

1.54

Dividend yield

0.00%

Revenue / share

$0.19

50-day avg

$0.53

200-day avg

$1.65

52-week high

$50.00

52-week low

$0.40

CEO

Jonathan Cohen

ETFs linked to AIDX

Broad-market and Healthcare sector ETFs an investor holding 20/20 Biolabs is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AIDX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AIDX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for 20/20 Biolabs?: 20/20 Biolabs trades under the ticker AIDX on NASDAQ.
Which exchange is AIDX listed on?: AIDX is listed on NASDAQ.
What sector does 20/20 Biolabs operate in?: 20/20 Biolabs is classified in the Healthcare sector (Medical - Care Facilities industry).
How can PortView help analyze AIDX in a portfolio?: PortView shows AIDX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.